BETHESDA, Md., Feb. 27, 2017 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) today announced the completion of a six-month enlargement of its Training and Research Institute (TRI) in Bethesda. The expansion permits PDA Education to increase its capacity for hands-on aseptic processing and lecture-based training at TRI.
The centerpiece of the buildout is a new 400 sq. ft. ISO Class 8 cleanroom that will house additional hands-on aseptic processing training courses. The cleanroom is enclosed by modular walls from Servicor and the air is processed with a HEPA air system.
"The hands-on aseptic processing instruction offered in an industrial setting at the Training and Research Institute is a critical component of PDA's educational program," said Craig Elliott, PDA Vice President of education. "PDA Education's Aseptic Processing Training Program provides an in-depth experience with the technologies associated with the manufacture of aseptically produced products, and now we have the capacity to train even more professionals each year."
PDA's aseptic processing program is highly valued and effective. "We've seen a dramatic increase in training demand recently, particularly from US regulators. Last year PDA trained over 300 US FDA personnel, but could not keep up with the increasing demand. This new capacity will allow us to meet the needs of the industry and the demand from regulators around the world," said Elliott.
PDA leads the pharmaceutical/biopharmaceutical industry in developing technical information and training in the areas of sterile drug manufacturing, aseptic processing, and other areas related to the manufacture and distribution of parenteral drug products.
"We offer a comprehensive and authoritative program in sterile manufacturing and aseptic processing that includes technical publications, articles, training and conferences," said Richard Johnson, PDA President.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients, through the expertise of over 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; firstname.lastname@example.org
SOURCE The Parenteral Drug Association (PDA)